RBM8A and Alzheimer disease: Using the workflow shown in Figure 1, we found that compared to control samples, RBM8A is significantly down-regulated in AD, P= 1.620e-19 and logFC (fold change) = -0.078 (Figure 2A), suggesting that low expression of RBM8A is associated with AD.